Difference between revisions of "Adenosine"
From WikiAnesthesia
Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses =Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia...") |
Chris Rishel (talk | contribs) m (Added embedded dosage calculation) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
| trade_names = | | trade_names = | ||
| drug_class = | | drug_class = | ||
| drug_class_color = | | drug_class_color = cardiovascular_antagonist | ||
| uses =Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia | | uses = Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia | ||
| contraindications = | | contraindications = | ||
| routes =Intravenous | | routes = Intravenous | ||
| dosage = | | dosage = | ||
| dosage_calculation = adenosine | |||
| mechanism = | |||
|mechanism=|adverse_effects=|time_onset=|duration=|metabolism=|halflife_redistribution=|halflife_elimination=|clearance=|protein_binding=}} | | adverse_effects = | ||
| time_onset = | |||
| duration = | |||
| metabolism = | |||
| halflife_redistribution = | |||
| halflife_elimination = | |||
| clearance = | |||
| protein_binding = | |||
}} | |||
Provide a brief summary of this drug here. | Provide a brief summary of this drug here. | ||
Latest revision as of 23:56, 29 March 2022
Adenosine
| Clinical data | |
| Uses |
Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia |
|---|---|
| Routes of administration |
Intravenous |
| Dosage | |
| Pharmacodynamics | |
| Pharmacokinetics | |
| Physical and chemical data | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Provide a brief summary of this drug here.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel